The ulcer sleuths: The search for the cause of peptic ulcers

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue SUPPL. 1, 2011, Pages 35-41

  Yeomans, Neville D ^a  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Etiology; Gastric acid; Helicobacter pylori; NSAIDs; Peptic ulcer

Indexed keywords

ACETYLSALICYLIC ACID; CODEINE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENACETIN; PHENYLBUTAZONE;

BLOOD VESSEL OCCLUSION; CIGARETTE SMOKING; DUODENUM ULCER; HELICOBACTER PYLORI; HUMAN; PEPTIC ULCER; PRIORITY JOURNAL; PSYCHOANALYSIS; PSYCHOSOMATICS; REVIEW; STOMACH ACID SECRETION; STOMACH ULCER;

EID: 78650793613     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06537.x     Document Type: Review

References (75)

1. Ho J, Lui I, Hui W-M, Ng MMT, Lam SK. A study on the correlation of duodenal-ulcer healing with campylobacter-like organisms. J Gastroenterol Hepatol. 1986; 1: 69-74.
2. Osler W. The Principles and Practice of Medicine. New York: D Appleton and Company, 1892.
3. Virchow R. Historisches, kritisches und positives zur lehre der unterleibsaffektionen. Virchows Arch. Pathol. Anat. Physiol. Klin. Med. 1853; 5: 362-4.
4. Berg BN. Gastric ulcers produced experimentally by vascular ligation. Arch. Surg. 1947; 54: 58-66.
5. Litthauer M. Experimentelle untersuchungen zur pathogenese des runden magengeschwurs. Virchows Arch. Pathol. Anat. Physiol. Klin. Med. 1909; 195: 317-41.
6. Somervell TH. Physiological gastrectomy: the operation of ligature of the arteries of the stomach to relieve hyperacidity and to prevent recurrent ulceration after gastro-enterostomy. Br. J. Surg. 1945; 33: 146-52.
7. Kamada T, Sato N, Kawano S, Fusamoto H, Abe H. Gastric mucosal hemodynamics after thermal or head injury: a clinical application of reflectance spectrophotometry. Gastroenterology 1982; 83: 535-40.
8. Cheney G, Bloomfield AL. Gastric function in cases of gastric and duodenal ulcer. J. Clin. Invest. 1928; 5: 511-20.
9. Kay AW. Effect of large doses of histamine on gastric secretion of HCl: an augmented histamine test. Br. Med. J. 1953; 2: 77-80.
10. Dragstedt LR. A concept of the etiology of gastric and duodenal ulcers. Gastroenterology 1956; 30: 208-20.
11. Wormsley KG, Grossman MI. Maximal histalog test in control subjects and patients with peptic ulcer. Gut 1965; 6: 427-35.
12. Zollinger RM, Ellison EH. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann. Surg. 1955; 142: 709-28.
13. Illingworth CFW. Inborn and extraneous factors in the aetiology of peptic ulcer. J. Roy. Coll. Surg. Edinb. 1956; 2: 14-23.
14. Beaumont W. Experiments and observations on the gastric juice and the physiology of digestion. Plattsburg: F.P. Allen-cited by Wolf S and Wolf HG (vide infra). 1833.
15. Wolf S, Wolf HG. Human Gastric Function: and Experimental Study of A Man and His Stomach. London: Oxford University Press, 1943.
16. Fordtran JS. The psychosomatic theory of peptic ulcer. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal Disease, 1st edn. Philadelphia: W B Saunders, 1973; 163-73.
17. Crohn BB. Peptic ulcer as a psychosomatic disease. Surg. Clin. North Am. 1947; 27: 309-14.
18. Castelnuovo-Tedesco P. Emotional antecedents of perforation of ulcers of the stomach and duodenum. Psychosom. Med. 1962; 24: 398-416.
19. Piper DW, Greig M, Shinners J, Thomas J, Crawford J. Chronic gastric ulcer and stress: a comparison of an ulcer population with a control population regarding stressful events over a lifetime. Digestion 1978; 18: 303-9.
20. Thomas J, Greig M, Piper DW. Chronic gastric ulcer and life events. Gastroenterology 1980; 78: 905-11.
21. Piper DW, McIntosh JH, Ariotti DE, Calogiuri JV, Brown RW, Shy CM. Life events and chronic duodenal ulcer: a case control study. Gut 1981; 22: 1011-7.
22. Alp MH, Court JH, Grant KA. Personality pattern and emotional stress in the genesis of gastric ulcer. Gut 1970; 11: 773-7.
23. Feldman M, Walker P, Green JL, Weingarden K. Life events stress and psychosocial factors in men with peptic ulcer disease. Gastroenterology 1986; 91: 1370-99.
24. Gilligan I, Fung L, Piper DW, Tennant C. Life events and chronic difficulties in duodenal ulcer: a case control study. J. Psychosom. Res. 1987; 31: 117-23.
25. Doll R, Hill AB. Lung cancer and other causes of death in relation to smoking. Br. Med. J. 1956; 2: 1071-81.
26. Doll R, Jones FA, Pygott F. Effect of smoking on the production and maintenance of gastric and duodenal ulcers. Lancet 1958; 271: 657-62.
27. Korman MG, Hansky J, Eaves ER, Schmidt GT. Influence of cigarette smoking on healing and relapse in duodenal ulcer disease. Gastroenterology 1983; 85: 871-4.
28. Sontag S, Graham DY, Belsito A et-al. Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. N. Engl. J. Med. 1984; 311: 689-93.
29. Whitfield PF, Hobsley M. Comparison of maximal gastric secretion iin smokers and non-smokers with and without duodenal ulcer. Gut 1987; 28: 557-60.
30. Quimby GF, Bonnice CA, Burstein SH, Eastwood GL. Active smoking depresses prostaglandin synthesis in human gastric mucosa. Ann. Intern. Med. 1986; 104: 616-9.
31. Douthwaite AH, Lintott GAM. Gastroscopic observations of the effects of aspirin and certain other substances in the stomach. Lancet 1938; 2: 1222-5.
32. Muir A, Cossar IA. Aspirin and ulcer. Br. Med. J. 1955; 2: 7-12.
33. Kuzell WC, Schaffarzick RW, Brown B, Mankle EA. Phenylbutazone (Butazolidin) in rheumatoid arthritis and gout. JAMA 1952; 149: 729-34.
34. Benstead JG. Deaths of two patients treated with phenylbutazone. Br. Med. J. 1953; 1: 711-2.
35. Beutler E, Bergenstal DM. Perforated duodenal ulcer with neutropenia and death in a patient receiving phenylbutazone therapy. Gastroenterology 1953; 25: 72-4.
36. Krainin P. Gastric ulcer with massive hemorrhage following use of phenylbutazone. JAMA 1953; 152: 31-2.
37. Shields WE, Adamson NEJ, Macgregor JB. Peptic ulcer perforation following administration of phenylbutazone. JAMA 1953; 152: 28-30.
38. Lövgren O, Allender E. Indomethacin and peptic ulcer. Br. Med. J. 1965; 1: 996.
39. Billington BP. Gastric ulcer: age, sex and a curious retrogression. Aust. Ann. Med. 1960; 9: 111-21.
40. Douglas RA, Johnston ED. Aspirin and chronic gastric ulcer. Med. J. Aust. 1961; 48: 893-7.
41. Gillies MA, Skyring AP. Gastric and duodenal ulcer: the association between aspirin ingestion, smoking and family history of ulcer. Med. J. Aust. 1969; 2: 280-5.
42. Chapman BL, Duggan JM. Aspirin and uncomplicated peptic ulcer. Gut 1969; 10: 443-50.
43. St John DJB, Yeomans ND, de Boer WGRM. Chronic gastric ulcer induced by aspirin: an experimental model. Gastroenterology 1973; 65: 634-41.
44. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol. 1971; 231: 232-5.
45. Elliott SL, Yeomans ND, Buchanan RRC, Smallwood RA. Efficacy of 12-months' misoprostol as prophylaxis against NSAID- induced gastric ulcers: a placebo controlled trial. Scand. J. Gastroenterol. 1994; 23: 171-6.
46. Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the high risk patient. Gastroenterology 2001; 120: 594-606.
47. Taha AS, Hudson N, Hawkey CJ et-al. Famotidine for the prevention of gastric and duodenal ulcers caused by non steroidal antiinflammatory drugs. N. Engl. J. Med. 1996; 334: 1435-9.
48. Hawkey CJ, Karrasch JA, Szczepañski L et-al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 1998; 338: 727-34.
49. Laine L, Harper S, Simon T et-al. A randomized trial comparing the effects of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. GE 1999; 117: 776-83.
50. Simon LS, Weaver AL, Graham DY et-al. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA 1999; 282: 1921-8.
51. Graham DY, Agrawal NM, Campbell DR et-al. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. Arch. Intern. Med. 2002; 162: 169-75.
52. Ihamäki T, Varis K, Siurala M. Morphological, functional and immunological state of the gastric mucosa in gastric carcinoma families: comparison with a computer-matched family sample. Scand. J. Gastroenterol. 1979; 14: 801-12.
53. Akdamar K, Ertan A, Agrawal NM, McMahon FG, Ryan J. Upper gastrointestinal endoscopy in normal asymptomatic volunteers. Gastrointest. Endosc. 1986; 32: 78-80.
54. Yeomans ND, Tulassay Z, Juhász L et-al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 1998; 338: 719-26.
55. Blaser M. An endangered species in the stomach. Sci. Am. 2005; 292: 38-45.
56. Bizzozero G. Ueber die schlauchförmigen Drüsen des Magendarmkanals und die Beziehungen ihres Epitheles zu dem Oberflächenepithel der Schleimhaut. Arch. mikrosk. anat. 1893; 42: 82-152.
57. Warren JR. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273.
58. Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273-5.
59. Goodwin CS. Helicobacter pylori: 10th aniversary of its culture in April 1982. Gut 1993; 34: 293-4.
60. McNulty CAM, Watson DM. Spiral bacteria of the gastric antrum. Lancet 1984; 323: 1068-9.
61. Langenberg ML, Tytgat GNJ, Schipper MEI, Rietra PJGM, Zanen HC. Campylobacter-like organisms in the stomach of patients and healthy individuals. Lancet 1984; 323: 1348-9.
62. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311.
63. Marshall BJ, McGechie DB, Rogers PA, Glancy RJ. Pyloric Campylobacter infection and gastroduodenal disease. Med. J. Aust. 1985; 142: 439-44.
64. Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ. Attempt to fulfill Koch's postulates for pyloric Campylobacter. Med. J. Aust. 1985; 142: 436-9.
65. Marshall BJ, Royce H, Annear DI et-al. Original isolation of Campylobacter pyloridis from human gastric mucosa. Microbios Lett. 1984; 25: 83-8.
66. Marshall BJ, Goodwin CS. Revised nomenclature of Campylobacter pyloridis. Int. J. Syst. Bacteriol. 1987; 37: 68.
67. Goodwin CS, Armstrong JA, Chilvers T et-al. Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pylori comb.nov. and Helicobacter mustelae comb. nov., respectively. Int. J. Syst. Bacteriol. 1989; 39: 397-405.
68. Yeomans ND. Bacteria in ulcer pathogenesis. In: Piper DW, ed. Peptic Ulceration Bailliere's Clin Gastroenterol. 1988; 2: 573-91.
69. Blackwood WS, Maudgal DP, Northfield TC. Prevention by bedtime cimetidine of duodenal-ulcer relapse. Lancet 1978; 1: 626-7.
70. Burland WL, Hawkins BW, Beresford J. Cimetidine treatment for the prevention of recurrence of duodenal ulcer: an international collaborative study. Postgrad. Med. J. 1980; 56: 173-6.
71. Marshall BJ, Goodwin CS, Warren JR et-al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet. 1988; 332: 1437-42.
72. Graham DY, Lew GM, Klein PD et-al. Effect of treatment of Helicobacter pylori infections on the long-term recurrence of gastric of duodenal ulcer: a randomised, controlled study. Ann. Intern. Med. 1992; 116: 705-8.
73. 2 generation in rats by colloidal bismuth subcitrate (De-Nol). Arch. Int. Pharmacodyn. Ther. 1987; 286: 308-19.
74. Hentschel E, Brandstätter G, Dragosics B et-al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N. Engl. J. Med. 1993; 325: 308-12.
75. NIH Consensus Development. Panel on Helicobacter pylori in peptic ulcer disease. Helicobacter pylori in peptic ulcer disease. J. Am. Med. Assoc. 1994; 272: 65-9.